News about Global Pharma

Biossmann Appoints Pankaj Kedia as Chief AI Officer to Drive Global Expansion and Innovation

Kedia, a renowned technology industry executive and AI thought-leader, joins Biossmann to spearhead its global expansion and drive innovation, positioning the company as a powerhouse in medical solutions.

Global Pharma | 24/05/2024 | By Abha |  955

Indica Labs and Hamamatsu Photonics Receive FDA Clearance for HALO AP Dx Digital Pathology Platform

HALO AP Dx is indicated for the primary diagnosis of surgical pathology slides prepared from formalin-fixed paraffin-embedded (FFPE) tissue scanned by the NanoZoomer® S360MD Slide scanner.

Global Pharma | 24/05/2024 | By Abha |  581

Gland Pharma Reports Remarkable Q4FY24 and FY24 Financial Performance

Gland Pharma Ltd. has announced its financial results for the fourth quarter (Q4FY24) and full year (FY24) ended on Mar 31, 2024.

Global Pharma | 23/05/2024 | By Aishwarya |  873

CAI and Fedegari Group to Deliver Turnkey Sterilization Solutions to Pharma Manufacturers

CAI has inked a strategic partnership with Fedegari Group, a manufacturer and service provider of high-performance sterilization systems.

Global Pharma | 23/05/2024 | By Aishwarya |  349

Strides Announces Best-Ever Financial Results for FY24

Strides Pharma Science Ltd. has published its consolidated financial results for the quarter (Q4FY24) and full year (FY24) ended March 31, 2024.

Global Pharma | 23/05/2024 | By Aishwarya |  1402

LabGenius Raises EUR 35 Million to Develop its ML-Driven Antibody Discovery Platform

LabGenius, a drug discovery company pioneering the use of machine learning for the discovery of novel therapeutic antibodies, has secured EUR 35 million in Series B financing round.

Global Pharma | 23/05/2024 | By Aishwarya |  805

Dragonfly Therapeutics Partners with Merck to Evaluate DF9001

Dragonfly Therapeutics, Inc. has entered into a clinical collaboration with Merck (known as MSD outside the US and Canada), to evaluate DF9001, Dragonfly's EGFR immune engager, in combination with Merck's anti-PD-1 therapy, KEYTRUDA (pembrolizumab), in patients with advanced solid tumors expressing EGFR.

Global Pharma | 22/05/2024 | By Aishwarya |  607

Valneva Names Dr. Hanneke Schuitemaker as Chief Scientific Officer

Valneva has appointed Dr. Hanneke Schuitemaker, PhD as Chief Scientific Officer (CSO) and Executive Committee member, effective June 3, 2024.

Global Pharma | 22/05/2024 | By Aishwarya |  482

PharmaLytica 2024 to Mark a Decade of Excellence and Innovation for Pharma Manufacturing

PharmaLytica Expo has been approaching its milestone 10th edition launch, scheduled from May 30, 2024 to June 1, 2024, at HITEX, Hyderabad a prominent pharmaceutical hub in India.

Global Pharma | 22/05/2024 | By Aishwarya |  922

Tower Cold Chain Announces its First Sustainability Report

Tower Cold Chain has recently published its first Sustainability Report, highlighting the company’s commitment to Environmental, Social and Governance (ESG) principles.

Global Pharma | 22/05/2024 | By Aishwarya |  392